J Paul Hastings

Affiliations

  • Chief Executive Officer at Nkarta Inc. (NKTX), 2025-06-20
  • at Engene Holdings Inc. (ENGN), 2025-06-16
  • Director at Pacira Biosciences Inc. (PCRX), 2024-06-13
  • Director at Proteon Therapeutics Inc (PRTO), 2018-06-11
  • Chairman & Ceo at Oncomed Pharmaceuticals Inc (OMED), 2017-10-12
  • Director at Relypsa Inc (RLYP), 2016-09-02
Insider Trading: Purchases See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
PCRX $29.30 853 $24,992.90 853 2013-05-15 Filing
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
NKTX $1.79 1,790 $3,204.10 320,069 2025-06-18 Filing
NKTX $2.20 17,378 $38,231.60 319,859 2025-01-15 Filing
NKTX $5.60 1,770 $9,912.00 240,737 2024-06-18 Filing
PCRX $28.38 880 $24,974.40 12,724 2024-06-13 Filing
NKTX $8.74 9,697 $84,751.78 390,507 2024-01-16 Filing